This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A multicentre double blind placebo controlled clin...
Clinical trial

A multicentre double blind placebo controlled clinical trial to assess efficacy and safety of Alvalin� (cathine hydrochloride) vs. placebo in 265 obese patients/group with a body mass index (BMI) between 30 and 45 kg/m2

Read time: 1 mins
Last updated:15th Oct 2012
Primary endpoint is the weight reduction of at least 10% overall in the treatment group with at least 5% greater weight reduction than in the placebo group) after 52 weeks of treatment.
Category Value
Study start date 2012-10-15

View full details